BACE1 and Alzheimer disease: Using kinetics and molecular docking studies, it was shown that both 6-FUmb and 8-FUmb possessed an anti-Alzheimer’s disease activity via noncompetitive inhibition of BACE1 in vitro, and the activity of 6-FUmb was more pronounced [21].